AtriCure (ATRC)
(Real Time Quote from BATS)
$21.37 USD
-0.68 (-3.08%)
Updated Aug 5, 2024 10:06 AM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Brokerage Reports
AtriCure, Inc. [ATRC]
Reports for Purchase
Showing records 41 - 59 ( 59 total )
Company: AtriCure, Inc.
Industry: Medical - Products
With AF FDA Label in Hand, ATRC Targets 500 More Cardiac Surgery Centers
Provider: KAUFMAN BROTHERS
Analyst: CERVANTES V
Company: AtriCure, Inc.
Industry: Medical - Products
In Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: AtriCure, Inc.
Industry: Medical - Products
Company: AtriCure, Inc.
Industry: Medical - Products
F2Q12 Earnings - MedTech Environment Remains Challenging (But Stable); Focus Remains on Share Capture
Provider: KAUFMAN BROTHERS
Analyst: CERVANTES V
Company: AtriCure, Inc.
Industry: Medical - Products
Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: AtriCure, Inc.
Industry: Medical - Products
Looking to Better Define Safety & Efficacy Threshold for Hybrid as it Moves into a Pivotal Trial
Provider: KAUFMAN BROTHERS
Analyst: CERVANTES V
Company: AtriCure, Inc.
Industry: Medical - Products
Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: AtriCure, Inc.
Industry: Medical - Products
All-in, Delivers In line 3Q11 Results; Steady as She Goes Heading into FDA
Provider: KAUFMAN BROTHERS
Analyst: CERVANTES V
Company: AtriCure, Inc.
Industry: Medical - Products
In Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: AtriCure, Inc.
Industry: Medical - Products
Gets FDA Panel Nod; Safety Vote Highlights Tough AF Patient Class
Provider: KAUFMAN BROTHERS
Analyst: CERVANTES V
Company: AtriCure, Inc.
Industry: Medical - Products
In Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: AtriCure, Inc.
Industry: Medical - Products
With Outcome Largely Unpredictable, FDA Panel Materials Don''t Look too Bad to Us
Provider: KAUFMAN BROTHERS
Analyst: CERVANTES V
Company: AtriCure, Inc.
Industry: Medical - Products
In Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: AtriCure, Inc.
Industry: Medical - Products
First, the FDA Panel; Next 3Q11 Earnings
Provider: KAUFMAN BROTHERS
Company: AtriCure, Inc.
Industry: Medical - Products
Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: AtriCure, Inc.
Industry: Medical - Products
Assigning Higher Probability ATRC Receives a Panel Nod or Manageable Delay
Provider: KAUFMAN BROTHERS
Company: AtriCure, Inc.
Industry: Medical - Products
In Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: AtriCure, Inc.
Industry: Medical - Products
We are initiating coverage with a BUY and $14 price target
Provider: KAUFMAN BROTHERS
Company: AtriCure, Inc.
Industry: Medical - Products
Medical Technology
Provider: KAUFMAN BROTHERS